Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys

Jul 19, 2025 - 03:00
 0  0
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys
The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0